Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA

Catalog # Availability Size / Price Qty
DY1598B
DY1598B-05
Ancillary Products Available
Human IL-29 / IL-28B (IFN-lambda 1 / 3) ELISA Standard Curve
1 Image
Product Details
Procedure
Citations (31)
FAQs
Supplemental Products
Reviews (4)

Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA Summary

Assay Type
Solid Phase Sandwich ELISA
Format
96-well strip plate
Sample Volume Required
100 µL
Assay Range
62.5 - 4,000 pg/mL
Sufficient Materials
For five or fifteen 96-well plates*
Specificity
Please see the product datasheet

* Provided that the recommended microplates, buffers, diluents, substrates and solutions are used, and the assay is run as summarized in the Assay Procedure provided.

This DuoSet ELISA Development kit contains the basic components required for the development of sandwich ELISAs to measure natural and recombinant human IL-29/IL-28B (IFN-lambda 1/3). The suggested diluent is suitable for the analysis of most cell culture supernate samples. Diluents for complex matrices, such as serum and plasma, should be evaluated prior to use in this DuoSet.

Product Features

  • Optimized capture and detection antibody pairings with recommended concentrations save lengthy development time
  • Development protocols are provided to guide further assay optimization
  • Assay can be customized to your specific needs
  • Economical alternative to complete kits

Kit Content

  • Capture Antibody
  • Detection Antibody
  • Recombinant Standard
  • Streptavidin conjugated to horseradish-peroxidase (Streptavidin-HRP)

Other Reagents Required

DuoSet Ancillary Reagent Kit 2 (5 plates): (Catalog # DY008) containing 96 well microplates, plate sealers, substrate solution, stop solution, plate coating buffer (PBS), wash buffer, and Reagent Diluent Concentrate 2.

The components listed above may be purchased separately:

PBS: (Catalog # DY006), or 137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2 - 7.4, 0.2 µm filtered

Wash Buffer: (Catalog # WA126), or 0.05% Tween® 20 in PBS, pH 7.2-7.4

Reagent Diluent: (Catalog # DY995), or 1% BSA in PBS, pH 7.2-7.4, 0.2 µm filtered

Substrate Solution: 1:1 mixture of Color Reagent A (H2O2) and Color Reagent B (Tetramethylbenzidine) (Catalog # DY999)

Stop Solution: 2 N H2SO4 (Catalog # DY994)

Microplates: R&D Systems (Catalog # DY990)

Plate Sealers: ELISA Plate Sealers (Catalog # DY992)

Scientific Data

Human IL-29 / IL-28B (IFN-lambda 1 / 3) ELISA Standard Curve

Product Datasheets

You must select a language.

x

Preparation and Storage

Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: IL-29/IL-28B (IFN-lambda 1/3)

Human/mouse IL-28A (IFN-lambda 2), IL-28B (IFN-lambda 3), and human IL-29 (IFN-lambda 1) are class II cytokine receptor ligands that are distantly related to members of the IL-10 family (11 - 13% amino acid (aa) sequence identity) and type I IFN family (15 - 19% aa sequence identity). These cytokines exert bioactivities that overlap those of type I IFNs, including antiviral activity and up-regulation of MHC class I antigen expression. The proteins signal through the same heterodimeric receptor complex that is composed of the IL-10 receptor beta (IL-10 R beta) and a novel IL-28 receptor alpha (IL-28 R alpha, also known as IFN-lambda R1). Mouse IL-28 shares 61%, 62%, and 52% aa identity with human IL-28A, IL-28B, and IL-29, respectively.

Long Name:
Interleukin 29
Entrez Gene IDs:
282618 (Human)
Alternate Names:
IFNl1; IFNl3; IFNlambda 1; IFNlambda 3; IL-29/IL-28B (IFN-lambda 1/3)

Assay Procedure

GENERAL ELISA PROTOCOL

Plate Preparation

  1. Dilute the Capture Antibody to the working concentration in PBS without carrier protein. Immediately coat a 96-well microplate with 100 μL per well of the diluted Capture Antibody. Seal the plate and incubate overnight at room temperature.
  2. Aspirate each well and wash with Wash Buffer, repeating the process two times for a total of three washes. Wash by filling each well with Wash Buffer (400 μL) using a squirt bottle, manifold dispenser, or autowasher. Complete removal of liquid at each step is essential for good performance. After the last wash, remove any remaining Wash Buffer by aspirating or by inverting the plate and blotting it against clean paper towels.
  3. Block plates by adding 300 μL Reagent Diluent to each well. Incubate at room temperature for a minimum of 1 hour.
  4. Repeat the aspiration/wash as in step 2. The plates are now ready for sample addition.

Assay Procedure

  1. Add 100 μL of sample or standards in Reagent Diluent, or an appropriate diluent, per well. Cover with an adhesive strip and incubate 2 hours at room temperature.
  2. Repeat the aspiration/wash as in step 2 of Plate Preparation.
  3. Add 100 μL of the Detection Antibody, diluted in Reagent Diluent, to each well. Cover with a new adhesive strip and incubate 2 hours at room temperature.
  4. Repeat the aspiration/wash as in step 2 of Plate Preparation.
  5. Add 100 μL of the working dilution of Streptavidin-HRP to each well. Cover the plate and incubate for 20 minutes at room temperature. Avoid placing the plate in direct light.
  6. Repeat the aspiration/wash as in step 2.
  7. Add 100 μL of Substrate Solution to each well. Incubate for 20 minutes at room temperature. Avoid placing the plate in direct light.
  8. Add 50 μL of Stop Solution to each well. Gently tap the plate to ensure thorough mixing.
  9. Determine the optical density of each well immediately, using a microplate reader set to 450 nm. If wavelength correction is available, set to 540 nm or 570 nm. If wavelength correction is not available, subtract readings at 540 nm or 570 nm from the readings at 450 nm. This subtraction will correct for optical imperfections in the plate. Readings made directly at 450 nm without correction may be higher and less accurate.

Citations for Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

31 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
    Authors: Reuschl, AK;Thorne, LG;Whelan, MVX;Ragazzini, R;Furnon, W;Cowton, VM;De Lorenzo, G;Mesner, D;Turner, JLE;Dowgier, G;Bogoda, N;Bonfanti, P;Palmarini, M;Patel, AH;Jolly, C;Towers, GJ;
    Nature microbiology
    Species: Human
    Sample Types: Cell Culture Supernates
  2. ZIKV induction of tristetraprolin in endothelial and Sertoli cells post-transcriptionally inhibits IFN?/? expression and promotes ZIKV persistence
    Authors: Schutt, WR;Conde, JN;Mladinich, MC;Himmler, GE;Mackow, ER;
    mBio
    Species: Human
    Sample Types: Cell Culture Supernates
  3. Identification of novel lactic acid bacteria with enhanced protective effects against influenza virus
    Authors: Sugimoto, A;Numaguchi, T;Chihama, R;Takenaka, Y;Sato, Y;
    PloS one
    Species: Human
    Sample Types: Cell Culture Supernates
  4. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1
    Authors: H Stölting, L Baillon, R Frise, K Bonner, RJ Hewitt, PL Molyneaux, ML Gore, Breathing, WS Barclay, S Saglani, CM Lloyd
    Mucosal Immunology, 2022-07-15;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  5. Deficiency in coatomer complex I causes aberrant activation of STING signalling
    Authors: A Steiner, K Hrovat-Sch, I Prigione, CH Yu, P Laohamonth, CR Harapas, RRJ Low, D De Nardo, LF Dagley, MJ Mlodzianos, KL Rogers, T Zillinger, G Hartmann, MP Gantier, M Gattorno, M Geyer, S Volpi, S Davidson, SL Masters
    Nature Communications, 2022-04-28;13(1):2321.
    Species: Human
    Sample Types: Cell Culture Supernates
  6. Inhibitor of growth protein 3 epigenetically silences endogenous retroviral elements and prevents innate immune activation
    Authors: Y Song, G Hou, J Diep, YS Ooi, NS Akopyants, SM Beverley, JE Carette, HB Greenberg, S Ding
    Nucleic Acids Research, 2021-12-16;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  7. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response
    Authors: SJ Oh, OS Shin
    Cells, 2021-03-02;10(3):.
    Species: Human
    Sample Types: Cell Culture Supernates
  8. Extracellular vesicles promote transkingdom nutrient transfer during viral-bacterial co-infection
    Authors: MR Hendricks, S Lane, JA Melvin, Y Ouyang, DB Stolz, JV Williams, Y Sadovsky, JM Bomberger
    Cell Reports, 2021-01-26;34(4):108672.
    Species: Human
    Sample Types: Cell Culture Supernates
  9. The regulation and pharmacological modulation of immune complex induced type III IFN production by plasmacytoid dendritic cells
    Authors: K Hjorton, N Hagberg, P Pucholt, ML Eloranta, L Rönnblom
    Arthritis Res. Ther., 2020-06-05;22(1):130.
    Species: Human
    Sample Types: Cell Culture Supernates
  10. Dysbiotic oral microbiota and infected salivary glands in Sj�gren's syndrome
    Authors: J Alam, A Lee, J Lee, DI Kwon, HK Park, JH Park, S Jeon, K Baek, J Lee, SH Park, Y Choi
    PLoS ONE, 2020-03-24;15(3):e0230667.
    Species: Human
    Sample Types: Cell Culture Supernates
  11. MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway
    Authors: H Xu, SJ Xu, SJ Xie, Y Zhang, JH Yang, WQ Zhang, MN Zheng, H Zhou, LH Qu
    Elife, 2019-02-08;8(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  12. IL-17A Attenuates IFN-? Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium
    Authors: M Niwa, T Fujisawa, K Mori, K Yamanaka, H Yasui, Y Suzuki, M Karayama, H Hozumi, K Furuhashi, N Enomoto, Y Nakamura, N Inui, T Suzuki, M Maekawa, T Suda
    J. Immunol., 2018-09-17;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  13. ZIKV Infection Induces an Inflammatory Response but Fails to Activate Types I, II, and III IFN Response in Human PBMC
    Authors: F Colavita, V Bordoni, C Caglioti, M Biava, C Castillett, L Bordi, S Quartu, M Iannetta, G Ippolito, C Agrati, MR Capobianch, E Lalle
    Mediators Inflamm., 2018-06-03;2018(0):2450540.
    Species: Human
    Sample Types: Cell Culture Supernates
  14. STAG2 deficiency induces interferon responses via cGAS-STING pathway and restricts virus infection
    Authors: S Ding, J Diep, N Feng, L Ren, B Li, YS Ooi, X Wang, KF Brulois, LL Yasukawa, X Li, CJ Kuo, DA Solomon, JE Carette, HB Greenberg
    Nat Commun, 2018-04-16;9(1):1485.
    Species: Human
    Sample Types: Cell Culture Supernates
  15. PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4
    Authors: N Ueno, N Nishimura, S Ueno, S Endo, H Tatetsu, S Hirata, H Hata, M Matsuoka, H Mitsuya, Y Okuno
    Oncogene, 2017-04-03;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  16. Mast cells are permissive for rhinovirus replication: potential implications for asthma exacerbations
    Authors: Charlene Akoto
    Clin. Exp. Allergy, 2017-01-26;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  17. Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro
    Authors: Luminita A Stanciu
    Antiviral Res., 2016-11-10;0(0):.
    Species: Human
    Sample Types: Cell Culture Supernates
  18. IFN-Alpha receptor-1 upregulation in PBMC from HCV naive patients carrying cc genotype. possible role of IFN-lambda.
    Authors: Lalle E, Bordi L, Caglioti C, Garbuglia A, Castilletti C, Taibi C, Cristofari F, Capobianchi M
    PLoS ONE, 2014-04-01;9(4):e93434.
    Species: Human
    Sample Types: Cell Culture Supernates
  19. Type III interferons, IL-28 and IL-29, are increased in chronic HCV infection and induce myeloid dendritic cell-mediated FoxP3+ regulatory T cells.
    Authors: Dolganiuc A, Kodys K, Marshall C, Saha B, Zhang S, Bala S, Szabo G
    PLoS ONE, 2012-10-10;7(10):e44915.
    Species: Human
    Sample Types: Serum
  20. Type III IFNs are produced by and stimulate human plasmacytoid dendritic cells.
    Authors: Yin Z, Dai J, Deng J, Sheikh F, Natalia M, Shih T, Lewis-Antes A, Amrute S, Garrigues U, Doyle S, Donnelly R, Kotenko S, Fitzgerald-Bocarsly P
    J Immunol, 2012-08-13;189(6):2735-45.
    Species: Human
    Sample Types: Cell Culture Supernates
  21. Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.
    Authors: Bierne H, Travier L, Mahlakoiv T, Tailleux L, Subtil A, Lebreton A, Paliwal A, Gicquel B, Staeheli P, Lecuit M, Cossart P
    PLoS ONE, 2012-06-14;7(6):e39080.
    Species: Human
    Sample Types: Cell Culture Supernates
  22. Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans.
    Authors: Popugaeva E, Witkowski PT, Schlegel M, Ulrich RG, Auste B, Rang A, Kruger DH, Klempa B
    PLoS ONE, 2012-04-24;7(4):e35587.
    Species: Primate
    Sample Types: Cell Culture Supernates
  23. Measles virus causes immunogenic cell death in human melanoma.
    Authors: Donnelly, O G, Errington-Mais, F, Steele, L, Hadac, E, Jennings, V, Scott, K, Peach, H, Phillips, R M, Bond, J, Pandha, H, Harrington, K, Vile, R, Russell, S, Selby, P, Melcher, A A
    Gene Ther, 2011-12-15;20(1):7-15.
    Species: Human
    Sample Types: Cell Culture Supernates
  24. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency.
    Authors: Sancho-Shimizu V, Perez de Diego R, Lorenzo L, Halwani R, Alangari A, Israelsson E, Fabrega S, Cardon A, Maluenda J, Tatematsu M, Mahvelati F, Herman M, Ciancanelli M, Guo Y, AlSum Z, Alkhamis N, Al-Makadma AS, Ghadiri A, Boucherit S, Plancoulaine S, Picard C, Rozenberg F, Tardieu M, Lebon P, Jouanguy E, Rezaei N, Seya T, Matsumoto M, Chaussabel D, Puel A, Zhang SY, Abel L, Al-Muhsen S, Casanova JL
    J. Clin. Invest., 2011-11-21;121(12):4889-902.
    Species: Human
    Sample Types: Cell Culture Supernates
  25. Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFN-lambda) in cutaneous lupus erythematosus.
    Authors: Zahn S, Rehkamper C, Kummerer BM, Ferring-Schmidt S, Bieber T, Tuting T, Wenzel J
    J. Invest. Dermatol., 2010-08-19;131(1):133-40.
    Species: Human
    Sample Types: Cell Culture Supernates
  26. Inhibition of dynamin-dependent endocytosis interferes with type III IFN expression in bacteria-infected human monocyte-derived DCs.
    Authors: Pietila TE, Latvala S, Osterlund P, Julkunen I
    J. Leukoc. Biol., 2010-07-07;88(4):665-74.
    Species: Human
    Sample Types: Cell Culture Supernates
  27. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.
    Authors: Stoltz M, Klingstrom J
    J. Virol., 2010-06-30;84(18):9140-8.
    Species: Human
    Sample Types: Cell Culture Supernates
  28. IRF5 is required for late-phase TNF secretion by human dendritic cells.
    Authors: Krausgruber T, Saliba D, Ryzhakov G
    Blood, 2010-03-17;115(22):4421-30.
    Species: Human
    Sample Types: Cell Culture Supernates
  29. IL-4 enhances IFN-lambda1 (IL-29) production by plasmacytoid DCs via monocyte secretion of IL-1Ra.
    Authors: Megjugorac NJ, Gallagher GE, Gallagher G
    Blood, 2010-03-16;115(21):4185-90.
    Species: Human
    Sample Types: Cell Culture Supernates
  30. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses.
    Authors: Wang Q, Nagarkar DR, Bowman ER, Schneider D, Gosangi B, Lei J, Zhao Y, McHenry CL, Burgens RV, Miller DJ, Sajjan U, Hershenson MB
    J. Immunol., 2009-11-04;183(11):6989-97.
    Species: Human
    Sample Types: Cell Culture Supernates
  31. Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes.
    Authors: Wolk K, Witte K, Witte E, Proesch S, Schulze-Tanzil G, Nasilowska K, Thilo J, Asadullah K, Sterry W, Volk HD, Sabat R
    J. Leukoc. Biol., 2008-02-15;83(5):1181-93.
    Species: Human
    Sample Types: Cell Culture Supernates

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs
Loading...

Reviews for Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA

Average Rating: 4.3 (Based on 4 Reviews)

5 Star
25%
4 Star
75%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA
By Helen Stoelting on 04/29/2021
Sample Tested: Cell culture supernatant

Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA
By Anonymous on 12/11/2020
Sample Tested: Cell culture supernatant

Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA
By Anonymous on 02/28/2019
Sample Tested: Cell culture supernatant

This ELISA is good as there are still few reagents for studying type III interferons. I have used it many times, successfully. My only concern is the quality of the standard. Although I aliquot the standard and store it at -80, but I can see obvious decreases in my standard curve over time. I have also used the DuoSet IFNB ELISA and I do not observe these decreases in the quality of the standard


Human IL-29/IL-28B (IFN-lambda 1/3) DuoSet ELISA
By Jordan Gaston on 12/01/2017
Sample Tested: Cell Lysates